Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Study to Assess the Implementation of Minimally Invasive Surgery in the Treatment of Grade III Hemorrhoids: Phase 1 of the IDEAL Framework

NCT06851312 is registered in ClinicalTrials.gov with Hospital Son Llatzer as lead sponsor.

NCT NCT06851312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06851312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Study to Assess the Implementation of Minimally Invasive Surgery in the Treatment of Grade III Hemorrhoids: Phase 1 of the IDEAL Framework
Lead sponsor
Hospital Son Llatzer
Phase
Observational
Overall status
Completed
Start date
May 1, 2025
Completion date
August 1, 2025
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhoidectomy, minimal invasive surgery